Ambu A/S (OTCMKTS:AMBBY) Releases Quarterly Earnings Results

Ambu A/S (OTCMKTS:AMBBY) released its earnings results on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, Zacks reports. Ambu A/S had a net margin of 10.00% and a return on equity of 10.35%.

Ambu A/S Trading Up 4.9%

Shares of AMBBY stock traded up $0.65 on Wednesday, reaching $13.85. 1,000 shares of the stock were exchanged, compared to its average volume of 744. The company has a quick ratio of 1.63, a current ratio of 2.72 and a debt-to-equity ratio of 0.08. Ambu A/S has a 1-year low of $12.56 and a 1-year high of $20.24. The stock has a market cap of $3.25 billion, a P/E ratio of 40.74 and a beta of 0.93. The firm has a 50 day moving average of $13.61 and a two-hundred day moving average of $14.55.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.